DEWPOINT THERAPEUTICS, INC.

Profile

Company Names

DEWPOINT THERAPEUTICS, INC.

Addresses

451 D STREET, SUITE 104, BOSTON, MA 02210

6 TIDE STREET, BOSTON, MA 02210

Phone Numbers

617-914-8448
(617) 819-5515

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$304,261,568.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2025-09-09 
$77,164,102.00 
$82,299,400.00 
$5,135,298.00 
Equity 
2
2022-01-26 
$149,999,989.00 
$149,999,989.00 
$0.00 
Equity 
1
2020-07-07 
$77,097,477.00 
$77,097,477.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SRINIVAS 
 
AKKARAJU, M.D. 
DIRECTOR
DEWPOINT THERAPEUTICS, INC.
SRINIVAS 
 
AKKARAJU, M.D., PH.D. 
DIRECTOR
DEWPOINT THERAPEUTICS, INC.
REGINA 
 
BARZILAY, PH.D. 
DIRECTOR
DEWPOINT THERAPEUTICS, INC.
BRUCE 
 
BEUTEL 
EXECUTIVE OFFICER
DEWPOINT THERAPEUTICS, INC.   |  ENVEDA THERAPEUTICS, INC.   |  GRO BIOSCIENCES INC.
OLIVER 
 
BRANDICOURT, M.D. 
DIRECTOR
DEWPOINT THERAPEUTICS, INC.
OLIVIER 
 
BRANDICOURT, M.D. 
DIRECTOR
DEWPOINT THERAPEUTICS, INC.
GUISEPPE 
A. 
CIARAMELLA, PH,D. 
DIRECTOR
DEWPOINT THERAPEUTICS, INC.
GIUSEEPPE 
 
CIARAMELLA, PH.D. 
DIRECTOR
DEWPOINT THERAPEUTICS, INC.
GIUSEPPE 
 
CIARAMELLA, PH.D. 
DIRECTOR
DEWPOINT THERAPEUTICS, INC.
GIUSEPPE 
A. 
CIARAMELLA, PH.D. 
DIRECTOR
DEWPOINT THERAPEUTICS, INC.
JUERGEN 
 
ECKHARDT, M.D. 
DIRECTOR
DEWPOINT THERAPEUTICS, INC.
JURGEN 
 
ECKHARDT, M.D. 
DIRECTOR
DEWPOINT THERAPEUTICS, INC.
LORI 
 
ESCOBEDO 
EXECUTIVE OFFICER
DEWPOINT THERAPEUTICS, INC.
ANTHONY 
A. 
HYMAN, PH.D. 
DIRECTOR
DEWPOINT THERAPEUTICS, INC.
ISAAC 
A. 
KLEIN, M.D., PH.D. 
EXECUTIVE OFFICER
DEWPOINT THERAPEUTICS, INC.
ELISABETH 
 
LEIDERMAN 
EXECUTIVE OFFICER
DECIBEL THERAPEUTICS, INC.   |  AUTOLUS THERAPEUTICS PLC   |  DEWPOINT THERAPEUTICS, INC.
MARK 
 
MURCKO, PH.D. 
DIRECTOR
SQZ BIOTECHNOLOGIES CO   |  DEWPOINT THERAPEUTICS, INC.
AMIR 
H. 
NASHAT 
DIRECTOR, EXECUTIVE OFFICER
LIVING PROOF INC   |  BIND BIOSCIENCES INC   |  BIND BIOSCIENCES, INC   |  DEWPOINT THERAPEUTICS, INC.
AMIR 
H. 
NASHAT, PH.D. 
DIRECTOR
DEWPOINT THERAPEUTICS, INC.
AMIR 
H. 
NASHAT, SC.D. 
DIRECTOR
ATYR PHARMA INC   |  DEWPOINT THERAPEUTICS, INC.
AMEET 
 
NATHWANI, M.D. 
DIRECTOR, EXECUTIVE OFFICER
DEWPOINT THERAPEUTICS, INC.
STEVEN 
 
NEIER, PH.D. 
DIRECTOR
DEWPOINT THERAPEUTICS, INC.
FABIO 
 
PUCCI, PH.D. 
DIRECTOR
BOUNDLESS BIO, INC.   |  DEWPOINT THERAPEUTICS, INC.
JOEL 
D. 
SENDEK 
EXECUTIVE OFFICER
DEWPOINT THERAPEUTICS, INC.
RICHARD 
A 
YOUNG, PH.D. 
DIRECTOR
DEWPOINT THERAPEUTICS, INC.
RICHARD 
A. 
YOUNG, PH.D. 
DIRECTOR
DEWPOINT THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-07-13
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-09-09 
2025-09-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-09-09 
2022-02-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-01-26 
2020-11-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-07-07 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#